However, no benefit of early chemotherapy initiation, solely based on CA125 increase [6], no CA125 elevation in nearly 10% of patients with EOC [27], and a weak correlation between CA125 kinetics with tumor size determined by computer tomography [28] restrained implementation of tumor marker kinetics to guide individual therapy so far. This evidence concerns the gene MUC16 and neoplasm.